Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Operating Income (2022 - 2026)

Cannabis Bioscience International Holdings' Operating Income history spans 5 years, with the latest figure at -$93259.0 for Q1 2026.

  • On a quarterly basis, Operating Income rose 27.84% to -$93259.0 in Q1 2026 year-over-year; TTM through Feb 2026 was -$398820.0, a 26.17% decrease, with the full-year FY2025 number at -$421365.0, up 13.32% from a year prior.
  • Operating Income hit -$93259.0 in Q1 2026 for Cannabis Bioscience International Holdings, up from -$95877.0 in the prior quarter.
  • Over the last five years, Operating Income for CBIH hit a ceiling of -$29634.0 in Q2 2024 and a floor of -$284866.0 in Q1 2023.
  • Historically, Operating Income has averaged -$134968.4 across 5 years, with a median of -$113419.0 in 2024.
  • Biggest five-year swings in Operating Income: soared 89.22% in 2024 and later plummeted 355.22% in 2025.
  • Tracing CBIH's Operating Income over 5 years: stood at -$183608.0 in 2022, then surged by 48.53% to -$94512.0 in 2023, then skyrocketed by 36.91% to -$59627.0 in 2024, then tumbled by 60.79% to -$95877.0 in 2025, then increased by 2.73% to -$93259.0 in 2026.
  • Business Quant data shows Operating Income for CBIH at -$93259.0 in Q1 2026, -$95877.0 in Q4 2025, and -$74784.0 in Q3 2025.